Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Sodium Deoxycholate
Therapeutic Area : Oncology
Study Phase : Phase I/ Phase II
Sponsor : Novotech
Deal Size : Inapplicable
Deal Type : Inapplicable
A Study to Evaluate the Combination of ATX-101 and Platinum-based Chemotherapy
Details : ATX-101 is a Other Small Molecule drug candidate, which is currently being evaluated in phase I/ phase II clinical studies for the treatment of Ovarian Neoplasms.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
March 24, 2021
Lead Product(s) : Sodium Deoxycholate
Therapeutic Area : Oncology
Highest Development Status : Phase I/ Phase II
Sponsor : Novotech
Deal Size : Inapplicable
Deal Type : Inapplicable